These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2308985)
1. Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Murakami S; Shimazaki C; Oku N; Itoh K; Takeda N; Fujita N; Ura Y; Nakagawa M Prog Clin Biol Res; 1990; 333():253-61. PubMed ID: 2308985 [No Abstract] [Full Text] [Related]
2. Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide. Shimazaki C; Inaba T; Murakami S; Fujita N; Nakagawa M; Gulati SC; Fried J; Clarkson BD; Wisniewolski R; Wang CY Prog Clin Biol Res; 1990; 333():311-9. PubMed ID: 2308988 [No Abstract] [Full Text] [Related]
3. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles. Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757 [TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion. Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931 [TBL] [Abstract][Full Text] [Related]
5. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads. Elias AD; Pap SA; Bernal SD Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434 [TBL] [Abstract][Full Text] [Related]
6. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268 [TBL] [Abstract][Full Text] [Related]
7. The use of immunorosettes for purging of bone marrow in childhood cancer. Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; Admiraal LG; Tetteroo PA; Figdor CG; van Leeuwen EF Prog Clin Biol Res; 1990; 333():337-44. PubMed ID: 2308990 [No Abstract] [Full Text] [Related]
8. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989 [No Abstract] [Full Text] [Related]
9. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
10. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads. Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147 [TBL] [Abstract][Full Text] [Related]
11. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144 [TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic manipulation of bone marrow and tumour cells: an update. Kemshead JT; Elsom G; Patel K Prog Clin Biol Res; 1990; 333():235-50; discussion 251. PubMed ID: 2408061 [TBL] [Abstract][Full Text] [Related]
13. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts. Uckun FM; Stong RC; Youle RJ; Vallera DA J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712 [TBL] [Abstract][Full Text] [Related]
14. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging. Janssen WE; Lee C; Gross S; Gee AP Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623 [TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468 [TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic removal of L1210V leukemic cells from mouse bone marrow ex vivo. Wiedłocha A; Paprocka M; Radzikowski C Arch Immunol Ther Exp (Warsz); 1991; 39(3):235-41. PubMed ID: 1810216 [TBL] [Abstract][Full Text] [Related]
17. Malignant leukemic cell separation by iron colloid immunomagnetic adsorption. Biéva CJ; Vander Brugghen FJ; Stryckmans PA Exp Hematol; 1989 Sep; 17(8):914-20. PubMed ID: 2670597 [TBL] [Abstract][Full Text] [Related]
18. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. Uckun FM; Ramakrishnan S; Houston LL J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia. Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555 [No Abstract] [Full Text] [Related]
20. CD9 is an unreliable antibody for bone marrow purging. Fort JA; Rios AM; Gross S; Janssen WE Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]